Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the safety and efficacy of cαStx1 and cαStx2 administered
concomitantly in children presenting early signs of Shiga Toxin-Producing Bacterial (STPB)
Infection.